Abelacimab (MAA868), a fully human IgG1 monoclonal antibody that binds to and blocks the activation of FXI, is an anticoagulant used in the study of thromboembolic diseases.
Purity:
94.90%
CAS Number:
[2098724-83-3]
Target:
Factor Xa
* VAT and and shipping costs not included. Errors and price changes excepted